The Project
Core Mission
First-in-Human Clinical Trial
The FLAIRVision project's primary objective is to conduct a groundbreaking first-in-human experiment in a blind patient, combining advanced polymer electrode arrays with cortical stimulation technology. This pivotal clinical trial will demonstrate that our approach can restore a level of vision that is genuinely useful in daily life, marking a transformative milestone in visual prosthesis development.
Technical Approach
Flexible Polymer Arrays
Advanced polymer-based electrode arrays designed to conform to the complex geometry of the visual cortex, providing superior tissue integration and durability for human implantation.
High-Resolution Stimulation
Innovative stimulation patterns that achieve resolution beyond the physical electrode count, enabling more detailed visual perception in the human visual cortex.
Clinical Translation
First-in-human trials designed to validate the safety and efficacy of our combined NeuraViPeR and HyperStim approach in real-world conditions with blind patients.